CurAegis Technologies, Inc. Logo

CurAegis Technologies, Inc.

CRGS

(2.5)
Stock Price

0,00 USD

-1703.59% ROA

41.35% ROE

-0x PER

Market Cap.

0,00 USD

-78.25% DER

0% Yield

-28506.67% NPM

CurAegis Technologies, Inc. Stock Analysis

CurAegis Technologies, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

CurAegis Technologies, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (41.35%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-0x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (-102%), which means it has a small amount of debt compared to the ownership it holds

4 Revenue Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

5 Net Profit Growth

This company's net profit has consistently grown over the past three years, showcasing a positive financial trend and making it an appealing investment opportunity.

6 Assets Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

7 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

8 ROA

The stock's ROA (-1703.59%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

CurAegis Technologies, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

CurAegis Technologies, Inc. Technical Stock Analysis
# Analysis Recommendation

CurAegis Technologies, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

CurAegis Technologies, Inc. Revenue
Year Revenue Growth
2000 11.000
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 126.000 100%
2008 121.000 -4.13%
2009 175.000 30.86%
2010 0 0%
2011 30.000 100%
2012 60.000 50%
2013 0 0%
2014 50.000 100%
2015 0 0%
2016 26.000 100%
2017 39.000 33.33%
2018 37.000 -5.41%
2019 15.000 -146.67%
2020 8.000 -87.5%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

CurAegis Technologies, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2000 731.000
2001 1.290.000 43.33%
2002 1.551.000 16.83%
2003 1.839.000 15.66%
2004 2.165.000 15.06%
2005 2.719.000 20.38%
2006 1.313.000 -107.08%
2007 710.000 -84.93%
2008 535.000 -32.71%
2009 520.000 -2.88%
2010 469.000 -10.87%
2011 751.000 37.55%
2012 936.000 19.76%
2013 1.203.000 22.19%
2014 1.154.000 -4.25%
2015 1.297.000 11.03%
2016 786.000 -65.01%
2017 1.469.000 46.49%
2018 1.262.000 -16.4%
2019 809.000 -56%
2020 392.000 -106.38%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

CurAegis Technologies, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 2.700.000 100%
2012 2.542.000 -6.22%
2013 1.625.000 -56.43%
2014 1.440.000 -12.85%
2015 1.459.000 1.3%
2016 2.994.000 51.27%
2017 2.782.000 -7.62%
2018 2.031.000 -36.98%
2019 1.503.000 -35.13%
2020 -1.980.000 175.91%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

CurAegis Technologies, Inc. EBITDA
Year EBITDA Growth
2000 -2.336.000
2001 -3.689.000 36.68%
2002 -4.395.000 16.06%
2003 -2.755.000 -59.53%
2004 -9.623.000 71.37%
2005 -4.560.000 -111.03%
2006 -7.045.000 35.27%
2007 -3.164.000 -122.66%
2008 -1.962.000 -61.26%
2009 -3.250.000 39.63%
2010 -3.000.000 -8.33%
2011 -3.372.000 11.03%
2012 -3.340.000 -0.96%
2013 -2.682.000 -24.53%
2014 -2.441.000 -9.87%
2015 -2.590.000 5.75%
2016 -3.860.000 32.9%
2017 -4.478.000 13.8%
2018 -5.113.000 12.42%
2019 -2.911.000 -75.64%
2020 1.944.000 249.74%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

CurAegis Technologies, Inc. Gross Profit
Year Gross Profit Growth
2000 38.000
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 6.000 100%
2008 16.000 62.5%
2009 85.000 81.18%
2010 0 0%
2011 13.000 100%
2012 15.000 13.33%
2013 0 0%
2014 -42.000 100%
2015 0 0%
2016 -101.000 100%
2017 -122.000 17.21%
2018 -73.000 -67.12%
2019 2.000 3750%
2020 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

CurAegis Technologies, Inc. Net Profit
Year Net Profit Growth
2000 -2.363.000
2001 -3.871.000 38.96%
2002 -4.577.000 15.42%
2003 -2.927.000 -56.37%
2004 -9.805.000 70.15%
2005 -5.445.000 -80.07%
2006 -7.727.000 29.53%
2007 -3.211.000 -140.64%
2008 -1.683.000 -90.79%
2009 -3.272.000 48.56%
2010 -3.053.000 -7.17%
2011 -3.433.000 11.07%
2012 -3.428.000 -0.15%
2013 -2.809.000 -22.04%
2014 -2.603.000 -7.91%
2015 -2.717.000 4.2%
2016 -4.162.000 34.72%
2017 -5.423.000 23.25%
2018 -6.308.000 14.03%
2019 -4.276.000 -47.52%
2020 508.000 941.73%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

CurAegis Technologies, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

CurAegis Technologies, Inc. Free Cashflow
Year Free Cashflow Growth
2000 -693.000
2001 -607.000 -14.17%
2002 -1.040.000 41.63%
2003 -1.010.000 -2.97%
2004 -940.000 -7.45%
2005 -1.335.000 29.59%
2006 -758.000 -76.12%
2007 -514.000 -47.47%
2008 -72.000 -613.89%
2009 -583.000 87.65%
2010 -1.807.000 67.74%
2011 -1.951.000 7.38%
2012 -2.324.000 16.05%
2013 -2.364.000 1.69%
2014 -2.324.000 -1.72%
2015 -2.549.000 8.83%
2016 -3.697.000 31.05%
2017 -4.642.000 20.36%
2018 -3.530.000 -31.5%
2019 -2.260.000 -56.19%
2020 -256.000 -782.81%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

CurAegis Technologies, Inc. Operating Cashflow
Year Operating Cashflow Growth
2000 -677.000
2001 -604.000 -12.09%
2002 -1.037.000 41.76%
2003 -1.009.000 -2.78%
2004 -805.000 -25.34%
2005 -1.269.000 36.56%
2006 -749.000 -69.43%
2007 -444.000 -68.69%
2008 -61.000 -627.87%
2009 -583.000 89.54%
2010 -1.804.000 67.68%
2011 -1.938.000 6.91%
2012 -2.187.000 11.39%
2013 -2.237.000 2.24%
2014 -2.267.000 1.32%
2015 -2.189.000 -3.56%
2016 -3.603.000 39.25%
2017 -4.222.000 14.66%
2018 -3.530.000 -19.6%
2019 -2.260.000 -56.19%
2020 -256.000 -782.81%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

CurAegis Technologies, Inc. Capital Expenditure
Year Capital Expenditure Growth
2000 16.000
2001 3.000 -433.33%
2002 3.000 0%
2003 1.000 -200%
2004 135.000 99.26%
2005 66.000 -104.55%
2006 9.000 -633.33%
2007 70.000 87.14%
2008 11.000 -536.36%
2009 0 0%
2010 3.000 100%
2011 13.000 76.92%
2012 137.000 90.51%
2013 127.000 -7.87%
2014 57.000 -122.81%
2015 360.000 84.17%
2016 94.000 -282.98%
2017 420.000 77.62%
2018 0 0%
2019 0 0%
2020 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

CurAegis Technologies, Inc. Equity
Year Equity Growth
2001 1.197.000
2002 1.899.000 36.97%
2003 927.000 -104.85%
2004 1.176.000 21.17%
2005 149.000 -689.26%
2006 -958.000 115.55%
2007 -2.007.000 52.27%
2008 -1.120.000 -79.2%
2009 -1.235.000 9.31%
2010 920.000 234.24%
2011 5.577.000 83.5%
2012 3.509.000 -58.93%
2013 1.335.000 -162.85%
2014 3.896.000 65.73%
2015 1.583.000 -146.11%
2016 1.583.000 0%
2017 -3.408.000 146.45%
2018 -8.479.000 59.81%
2019 -12.203.000 30.52%
2020 -14.222.000 14.2%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

CurAegis Technologies, Inc. Assets
Year Assets Growth
2001 3.106.000
2002 3.216.000 3.42%
2003 2.806.000 -14.61%
2004 3.420.000 17.95%
2005 2.020.000 -69.31%
2006 1.201.000 -68.19%
2007 516.000 -132.75%
2008 695.000 25.76%
2009 379.000 -83.38%
2010 1.786.000 78.78%
2011 6.198.000 71.18%
2012 4.053.000 -52.92%
2013 1.537.000 -163.7%
2014 4.010.000 61.67%
2015 1.741.000 -130.33%
2016 2.435.000 28.5%
2017 2.200.000 -10.68%
2018 150.000 -1366.67%
2019 251.000 40.24%
2020 284.000 11.62%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

CurAegis Technologies, Inc. Liabilities
Year Liabilities Growth
2001 1.909.000
2002 552.000 -245.83%
2003 1.306.000 57.73%
2004 1.963.000 33.47%
2005 1.863.000 -5.37%
2006 2.159.000 13.71%
2007 2.523.000 14.43%
2008 1.815.000 -39.01%
2009 1.614.000 -12.45%
2010 866.000 -86.37%
2011 621.000 -39.45%
2012 544.000 -14.15%
2013 202.000 -169.31%
2014 114.000 -77.19%
2015 158.000 27.85%
2016 852.000 81.46%
2017 5.608.000 84.81%
2018 8.629.000 35.01%
2019 12.454.000 30.71%
2020 14.506.000 14.15%

CurAegis Technologies, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.08
Price to Earning Ratio
-0x
Price To Sales Ratio
0x
POCF Ratio
-0
PFCF Ratio
0
Price to Book Ratio
-0
EV to Sales
635.4
EV Over EBITDA
-3.27
EV to Operating CashFlow
-4.22
EV to FreeCashFlow
-4.22
Earnings Yield
-845.04
FreeCashFlow Yield
0
Market Cap
0,00 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.68
Graham NetNet
-0.25

Income Statement Metrics

Net Income per Share
-0.08
Income Quality
0.53
ROE
0.41
Return On Assets
-17.04
Return On Capital Employed
0.56
Net Income per EBT
1
EBT Per Ebit
1.76
Ebit per Revenue
-161.87
Effective Tax Rate
0.14

Margins

Sales, General, & Administrative to Revenue
100.2
Research & Developement to Revenue
53.93
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.13
Operating Profit Margin
-161.87
Pretax Profit Margin
-285.07
Net Profit Margin
-285.07

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.04
Free CashFlow per Share
-0.04
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.78
Return on Tangible Assets
-17.04
Days Sales Outstanding
0
Days Payables Outstanding
61320
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0.01
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,24
Tangible Book Value per Share
-0.24
Shareholders Equity per Share
-0.24
Interest Debt per Share
0.21
Debt to Equity
-0.78
Debt to Assets
38.04
Net Debt to EBITDA
-3.27
Current Ratio
0
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-0.78
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

CurAegis Technologies, Inc. Dividends
Year Dividends Growth

CurAegis Technologies, Inc. Profile

About CurAegis Technologies, Inc.

CurAegis Technologies, Inc. does not have significant operations. Previously, it was engaged in the development and marketing of technologies in the areas of wellness, safety, and power. The company was formerly known as Torvec, Inc. and changed its name to CurAegis Technologies, Inc. in June 2016. CurAegis Technologies, Inc. was founded in 1996 and is based in Rochester, New York. On August 4, 2021, an involuntary petition for liquidation under Chapter 7 was filed against CurAegis Technologies, Inc. in the U.S. Bankruptcy Court for the Western District of New York. On August 31, 2021, the involuntary petition was approved by the Court.

CEO
Mr. James R. Donnelly
Employee
7
Address
350 Linden Oaks
Rochester, 14625

CurAegis Technologies, Inc. Executives & BODs

CurAegis Technologies, Inc. Executives & BODs
# Name Age

CurAegis Technologies, Inc. Competitors